ASPN — Aspen Aerogels Income Statement
0.000.00%
- $455.68m
- $405.76m
- $452.70m
- 75
- 91
- 27
- 70
Annual income statement for Aspen Aerogels, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 100 | 122 | 180 | 239 | 453 |
Cost of Revenue | |||||
Gross Profit | 14.6 | 9.94 | 4.98 | 56.9 | 183 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 122 | 158 | 260 | 288 | 426 |
Operating Profit | -21.6 | -36.9 | -79.2 | -49.2 | 27 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -21.8 | -37.1 | -82.7 | -45.8 | 15.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -21.8 | -37.1 | -82.7 | -45.8 | 13.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -21.8 | -37.1 | -82.7 | -45.8 | 13.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.8 | -37.1 | -82.7 | -45.8 | 13.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.827 | -1.34 | -2.1 | -0.66 | 0.509 |